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ABSTRACT
Background. The paper describes prevalence, impairments, patterns of co-morbidity and other
correlates of DSM-IV social phobia in adolescents and young adults, separating generalized and
non-generalized social phobics.
Methods. Data are derived from the baseline investigation of the Early Developmental Stages of
Psychopathology Study (EDSP), a prospective longitudinal community study of 3021 subjects, aged
14–24. Diagnoses were based on the DSM-IV algorithms of an expanded version of the Composite
International Diagnostic Interview.
Results. Lifetime prevalence of DSM-IV}CIDI social phobia was 9±5% in females and 4±9% in
males, with about one-third being classified as generalized social phobics. Twelve-month prevalence
was only slightly lower, indicating considerable persistence. Respondents with generalized social
phobia reported an earlier age of onset, higher symptom persistence, more co-morbidity, more
severe impairments, higher treatment rates and indicated more frequently a parental history of
mental disorders than respondents with non-generalized social phobia.
Conclusions. History of DSM-IV social phobia was found to be quite prevalent in 14–24 year-olds.
The generalized subtype of social phobia was found to have different correlates and to be
considerably more persistent, impairing and co-morbid than non-generalized social phobia.
Although generalized social phobics are more likely than non-generalized social phobics to receive
mental health treatments, the treatment rate in this sample was low despite the fact that mental
health services are free in Germany.
INTRODUCTION
In the past two decades the prevalence of social
phobia has been studied in several community
studies throughout the world. Most of the earlier
studies were based on DSM-III criteria assessed
with the Diagnostic Interview Schedule (DIS)
(Robins et al. 1981). The Epidemiologic Catch-
ment Area (ECA) programme found the lifetime
(LT) prevalence of DSM-III social phobia to be
" Address for correspondence: Dr Hans-Ulrich Wittchen, Max
Planck Institute of Psychiatry, Clinical Psychology and Epidemi-
ology, Kraepelinstrasse 2, 80804 Mu$ nchen, Germany.
2±8% (Regier et al. 1990). Similar DIS}DSM-III
estimates were obtained in community surveys
carried out in Munich (2±5%) (Wittchen et al.
1992), Edmonton (1±7%) (Bland et al. 1988),
Zurich (3±2%) (Angst & Dobler-Mikola, 1985)
and New Zealand (3±9%) (Wells et al. 1989).
These prevalence could be regarded as fairly
conservative estimates due to the fact that the
version of the DIS used in these surveys assessed
social fears as part of the simple phobia section,
covering only a limited range of social fear
situations (Davidson et al. 1993; Walker &
Stein, 1995; Magee et al. 1996; Wittchen &
Beloch, 1996). It is noteworthy that the DIS}
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DSM-III rates are also considerably lower than
those found in previous non-DIS studies by
Marks (1979; 8%), Bryant & Towers (1974;
10%) and DiNardo et al. (1983; 13±3%).
This ‘underestimation’ problem, which poss-
ibly was due to the lack of precision in DSM-III,
has been corrected in the successor to the DIS,
the World Health Organization’s Composite
International Diagnostic Interview (CIDI)
(WHO, 1990), by developing a separate social
phobia module according to the diagnostic
criteria of DSM-III-R and the ICD-10, Diag-
nostic Criteria for Research. This module evalu-
ates more types of social fears than the original
DIS. Community epidemiological surveys using
the CIDI have obtained considerably higher
estimates of social phobia than all earlier studies,
including a 13±3% lifetime DSM-III-R prev-
alence in the US-National Comorbidity Survey
(Magee et al. 1996) and a 16±1% lifetime ICD-10
prevalence in Basel, Switzerland (Wacker et al.
1992). Although some part of these higher
prevalence estimates than in the earlier
DIS}DSM-III surveys might be due to the
expanded DSM-III-R and ICD-10 criteria,
differences in sample composition or field proc-
edures and the much more comprehensive
assessment of social fears are likely to be
responsible for most of the increase (Stein et al.
1994; Wittchen & Beloch, 1996).
Despite the substantial differences in esti-
mated prevalence, there is good agreement across
studies on risk factors for social phobia in
adults. Rates of social phobia are consistently
found to be slightly higher among women than
men, higher in younger as compared to older age
cohorts, and inversely associated with socio-
economic status (Bourdon et al. 1988; Bourdon,
1993; Magee et al. 1996). There is also agreement
across studies that social phobia usually has its
onset in childhood or adolescence, usually goes
untreated (Burns, 1980; Ross, 1993; Schneier et
al. 1992; Magee et al. 1996), and is associated
with poor school and work performance, school
dropout, unemployment, and alcohol abuse
(Mullaney & Trippet, 1979; Liebowitz et al.
1985; Davidson et al. 1993; Wittchen & Beloch
1996). There is also consistent evidence that
social phobics have a higher risk than people
with no social phobia of other anxiety disorders,
major depression and substance use disorders
(Merikangas et al. 1996). These other disorders
seem to occur mostly secondary to social phobia.
However, this conclusion should be interpreted
with caution due to the retrospective assessment
strategies used in these studies. Other potentially
important vulnerability and risk factors for the
development of social phobia, like familial
liability (Stein et al. 1998) and childhood
‘behavioral inhibition’ (Biederman et al. 1990;
Rosenbaum et al. 1992) have not yet been
studied in any epidemiological study.
Little is known about the severity and impair-
ments due to social phobia in community
samples (Magee et al. 1996). The only assessment
of impairment in most studies was a single
yes–no question about whether social phobia
interfered a lot with life and activities. More
fine-grained assessments of impairment have not
been made. Neither has there been an attempt to
sort out the impairment due to social phobias
from that due to co-morbid conditions
(Wittchen, 1996). Furthermore, few epidemio-
logical data exist concerning the frequency of
subtypes of social phobia (Stein et al. 1994,
1996). No epidemiological study up to now has
investigated the DSM-IV subtype of generalized
social phobia.
This report provides information about the
lifetime and 12-month prevalences of social
fears and DSM-IV social phobia in a community
sample of adolescents and young adults aged
14–24. This emphasis on fairly young respon-
dents allows a more powerful age-group-specific
analysis of risk factors, impairments and corre-
lates of social phobia than in previous studies.
We emphasize differences between generalized
and non-generalized social phobia in symptoms,
severity, co-morbidity, correlates and disorder-
specific impairments and disabilities and will
further reports some findings about the as-
sociation of parental psychopathology and
behavioural inhibition with social phobia.
METHOD
The data were collected as part of the baseline
investigation of the Early Developmental Stages
of Psychopathology (EDSP) study. The EDSP is
a research programme funded by the German
Ministry of Research and Technology, designed
to collect data on the prevalence, risk factors,
co-morbidity and course of mental disorders in
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a community sample of 3021 adolescents and
young adults. The study consists of a baseline
survey and two follow-up surveys at approxi-
mately 15 and 30 months after baseline and a
separate family genetic investigation of the
parents of respondents. A full description of the
study is presented elsewhere and thus the
methods will be discussed only briefly here
(Wittchen et al. 1998a).
Sample
The EDSP sample was drawn from the 1994
official population register of all residents in
metropolitan Munich. All registrants who were
expected to be 14–24 years-of-age during the
first half of 1995 were eligible for selection.
Because the study was designed as a longitudinal
investigation with special interest in the onset
and early development of mental disorders,
14–15 year-olds were oversampled. From 4263
individuals eligible for the study, a total of 3021
interviews were completed resulting in a response
rate of 71%.To account for differential sampling
probabilities and non-response, the data
reported in this paper were weighted to match
the age-sex distribution of the sampling frame.
Approximately one-third of the sample was
attending at the time of study or had attended
Gymnasium (secondary education between ages
of 10 to 19 which prepares students for entrance
to university) and another third university.
Lower school educational status was reported
by 11% (Hauptschule, or mandatory basic
school) and intermediate school by 18±4%
(Realschule, or intermediate advanced school
between Gymnasium and Hauptschule allowing
qualification for specific university curricula).
Consistent with the mandatory schooling laws,
only 0±5% of respondents dropped out of school
without any degree. Only 22±6% of all study
participants were in the work force at the time of
interview and another 4±9% were registered as
being unemployed. The majority of respondents
(64%) were living with their parents and only a
small number were married (3%) at the time of
interview. The vast majority (60±2%) of respon-
dents were classified into middle class.
Measures
Psychopathological and diagnostic assessments
were based on the computer-assisted personal
interview (CAPI) version of the Munich-Com-
posite International Diagnostic Interview (M-
CIDI) (Wittchen & Pfister, 1997). The M-CIDI
is a modified version of the World Health
Organization (WHO) CIDI, version 1.2 supple-
mented by questions to cover DSM-IV and
ICD-10 criteria (Wittchen & Pfister, 1997). The
M-CIDI allows for the assessment of symptoms,
syndromes and diagnoses of 48 mental disorders
along with information about onset, duration,
and severity. The CAPI version of the M-CIDI
was supplemented by a separate respondents’
booklet that included several scales andquestion-
naires that are of importance for the longitudinal
component of our study. The booklet also
included cognitive aids to assist the respondent
in dating symptom onset and recency, answering
complicated symptom questions, and identifying
course patterns. Diagnostic findings reported in
this paper are based on the CIDI}DSM-IV
algorithms (Wittchen & Pfister, 1997) without
using the DSM-IV hierarchy rules. The mean
duration for completing the computerized
(CAPI) M-CIDI, including questionnaires, was
77 min.
Because the M-CIDI social phobia module
contains more detailed questions for assessing
DSM-IV criteria than previous versions, the
assessment procedure and the algorithms will be
described briefly. The section begins with a stem
question to sensitize the respondent to sub-
sequent seven questions about specific social
fear situations. Before reading this stem question
the respondent was instructed to open a re-
spondent booklet to review visually seven
situational clusters of situations along with more
detailed examples. These seven situations are
identical to the standard CIDI and were coded
for use in the diagnostic algorithm. This visual
aid presented up to three more specific examples
for each of the seven standard CIDI situational
fear ‘cluster ’ questions (i.e. when asking for ‘ever
having strong fears of attending social affairs,
going to a party or meeting’, the following
additional situations, taken from various social
phobia questionnaires, were additionally visu-
ally presented for subsequent coding: partici-
pating in small groups, going to a party, entering
a room when others are waiting). Respondents
were asked to give a concrete example for each
item endorsed to allow for clarification by the
interviewer and for later editing. After at least
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one fear situation was elicited, a subsequent
series of nine questions was asked about cog-
nitive elements of anxiety such as fear of
blushing, fear of panic, fear of showing
symptoms of anxiety, etc. DSM-IV Criterion B
was assessed by instructing subjects to turn to a
list of anxiety symptoms in the respondent
booklet and to indicate all symptoms of anxiety
occurring in such situations. Because DSM-IV
requires that cued anxiety reactions occur almost
invariably, the M-CIDI algorithm required at
least two such symptoms occurring ‘almost
always’ when thinking about, or when being
exposed to such situations. Criterion C was
assessed by asking the respondent whether they
considered either the anxiety or the avoidance to
be excessive or unreasonable. Criterion D was
assessed by determining if the respondent fre-
quently avoided the situations or, if not, endured
the situations with distress. Criterion E was
assessed by determining if respondents reported
that : (a) the social fears or avoidance interfered
a lot with at least one of three social role areas ;
(b) they were persistently upset for a period of at
least 1 month; or (c) they sought professional
help for the fears. The persistence of social
phobia (criterion F) by assessing the duration of
symptoms and whether the phobic anxiety
reactions occur at least mostly over this time
period. The DSM-IV diagnostic exclusion G
and H were assessed with specific probe
questions to evaluate medical (including
stuttering, speech defects, abnormal eating
behaviours, mental disorders such as panic) or
substance-use related syndromes. Throughout
the paper, reported DSM-IV prevalence rates
take into account the above mentioned exclusion
criteria.
A diagnosis of social phobia, generalized
subtype is assigned by the expanded M-CIDI
diagnostic algorithm, whenever: (a) all diag-
nostic criteria were met ; (b) additionally, three
or more of the overall six specific qualifying
classes of social fear situations presented were
reported; and (c) the person acknowledged that
fear and avoidance of these situations almost
always were present since onset. It is noteworthy
that the M-CIDI includes a seventh residual
category of ‘other ’ situations when respondents
were in the centre of attention of others. The
examples given to this item, however, were
reviewed by the clinical editors and were then in
most cases assigned to the six main classes of
social fears. In terms of the critical threshold of
number of situations the M-CIDI generalized
phobia algorithm compares well to the pro-
cedure used by Manuzza et al. (1995). Our
strategy requires at least three situational clusters
out of a total of six, including test and
performance fears ; Manuzza et al. (1995) cases
mostly had at least three interactional and
frequently one additional performance fear out
of a total of ten.
The diagnostic 1-week test–retest reliability of
the M-CIDI social phobia module, investigated
in a general population sample of 60 cases, had
a kappa of 0±72 and slightly higher for the
generalized subtype (kappa: 0±80) (Wittchen,
1994; Wittchen & Pfister 1997; Wittchen et al.
1998b). Validity of the M-CIDI diagnoses of
social phobia as compared to independent
clinical consensus diagnoses by treating
physicians in a sample of 68 randomly chosen
patients had a kappa of 0±80, a negative
predictive value of 0±714, and a positive pre-
dictive value of 1±0 (Reed et al. 1998).
Additional measures
Behavioural inhibition was assessed with the
German version of the Retrospective Self-
Report of Inhibition questionnaire (RSRI;
Resnick et al. 1992). This questionnaire consists
of a set of 30 questions reflecting several domains
(i.e. sympathetic nervous system activity, fear of
things, etc) to be answered retrospectively for
the time as a child (school grades 1 to 6).
Although the authors suggested a two-factor
solution, preliminary psychometric investi-
gations revealed only one main factor; thus for
the present analysis subjects we will examine the
role of high (as defined as a standard score of z
! 0±49) behavioural inhibition. Parental psy-
chopathology was assessed by the M-CIDI
family history module (Wittchen & Pfister 1997),
that consists of a series of 42 complex questions
to assessing for the respondent father andmother
as well as other family members indicators
(sought professional help, noticed key
symptoms, their persistence, etc.) for various
types of mental disorders (anxiety, depressive
somatoform, psychotic, substance use disorder).
Since pilot-comparisons of findings from these
questions with the results of an independent
personal assessment of the respondents’
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(Wittchen et al. 1999) parents revealed only
moderate agreement for specific diagnoses, this
paper restricts the presentation to a dichotomous
variable that was found to be sufficiently
concordant with the findings of separate per-
sonal parents interviews to warrant investigation
(kappa of 0±64): parental history of mental
disorders as evidenced either by a known mental
health treatment history or perceived problems
in the areas of anxiety, depression, somatoform
disorders. Work disability and productivity is
indicated by number of days in the past month
the person was completely unable (disability) to
perform his social roles, or was at least signifi-
cantly limited (productivity) because of his
symptoms. Help-seeking and treatment infor-
mation was assessed comprehensively including
health insurance data; from this comprehensive
data base, however, only data about social
phobia-specific interventions by medical doctors
and other mental health practitioners as well as
mental health interventions for other reasons
will be presented.
Interviewer and field work
The survey staff was highly experienced and
consisted of 10 clinical interviewers and 25
professional health-research interviewers. All
had extensive experience in diagnostic inter-
viewing including the CIDI and in the de-
velopmental work of the M-CIDI. All inter-
viewers received two full weeks of training
followed by at least 10 practice interviews that
were closely monitored by our staff. Immediately
prior to the beginning of the study, an additional
training session was conducted. Contact
attempts were initiated by mail. A time and
location for the interview were then established
by phone. Most interviews took place in the
home of the probands. Written and signed
informed consent was obtained from all partici-
pants. To enhance participation, various special
efforts were made during the study ranging from
assigning different interviewers at different times
to contact hard to reach respondents to financial
incentives for participation.
Analyses
To account for differential sampling proba-
bilities and non-response, the data reported in
this paper were weighted by age and sex to
match the distribution of the sampling frame.
All statistical analyses, except χ#-tests, were
done using SAS software (SAS, 1996) and
relative weights. To account for design effects
introduced by using weighted data, all standard
errors and statistical tests were estimated using
SUDAAN (Shah et al. 1996).
RESULTS
Lifetime (LT) and 12-month prevalence by age
and gender
Overall, 4±9% of males and 9±5% of females
aged 14–24 meet lifetime DSM-IV criteria for
social phobia (Table 1). About one-third of
lifetime cases meet study criteria for the
generalized subtype. Overall, females have
significantly higher lifetime and cross-sectional
rates than males (P! 0±001). Lifetime estimates
for 14–17 year-olds are lower than those for
18–24 year-olds. The majority of lifetime cases
also meet diagnostic criteria in the past 12
months. The persistence of generalized social
phobia (males, 76±8%; females, 90%) from LT
into the past 12-months is slightly higher than in
isolated social phobia (males 59±5%; females
69±2; P¯ 0±03).
In an attempt to cover DSM-IV diagnostic
exclusion criteria G and F, we examined what
proportion of social phobics might have de-
veloped their disorder as a result of substance
use or of somatic illnesses and conditions. No
case was identified with a suspicious substance
factor that might be related to the onset of social
phobia. However, two social phobics had at
least mild chronic physical disablement (partial
amputation of three fingers, noticeable limping
due to early childhood accidents and subsequent
operation) and four had visible physical defects
(two cases of severe long-lasting acne, facial
scars due to childhood accident, nose–mouth
disfigurement). In these latter cases, we found no
indications in the verbatim description of social
fears that the social phobia is directly due to any
of the reported or observed disabilities or
handicaps. We also closely examined cases
reporting social fears of ‘eating and drinking
while someone watches ’ with regard to the
presence of eating disorders (see below). We
found only four cases with DSM-IV eating
disorders who reported fairly isolated fears of
this type; a number small enough to have no
important impact on estimated prevalence.
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Table 1. Lifetime cumulative incidence (LT-CI ) and 12-month prevalence of generalized and non-generalized social phobia among
14–24 year-olds and relative persistence (ratio LT to 12-month rates)
LT-CI 12-month prevalence
12-m:LT ratio
Male Female Total Male Female Total persistence
Diagnostic group}age N % .. P N % .. N % N % .. P N % .. N % Male Female
Non-generalized SP
14–17 years 10 2±2 0±51 17 3±7 0±72 27 2±9 7 1±5 0±71 13 2±9 0±93 20 2±2 68±2 78±4
18–24 years 45 4±4 0±87 83 7±8 1±6 128 6±1 25 2±4 0±74* 0±001 56 5±2 0±12 81 3±9 54±5 66±7
Total 55 3±7 0±57* 0±000 100 6±5 0±72 155 5±12 33 2±2 0±43* 69 4±5 0±61 102 3±4 59±5 69±2
Generalized SP
14–17 years 3 0±6 0±52 8 1±8 0±52 11 1±2 2 0±4 0±29 6 1±3 0±82 8 0±9 66±7 72±2
18–24 years 16 1±6 0±59 38 3±6 0±91 54 2±6 14 1±5 0±7 35 3±3 0±91 49 2±3 93±7 91±7
Total 19 1±3 0±30* 0±001 46 3±0 0±52 65 2±2 16 1±0 0±28* 0±001 41 2±7 0±50 57 1±9 76±8 90±0
DSM-IV social phobia
14–17 years 13 2±7 0±78 24 5±5 0±99 37 4±0 9 2±0 0±74 19 4±3 0±93 28 3±0 74±1 78±2
18–24 years 61 5±9 0±93 121 11±3 1±5 182 8±7 39 3±8 0±95* 0±000 91 8±5 1±3 130 6±2 54±4 75±2
Total 74 4±9 0±64* 0±000 146 9±5 0±87 220 7±3 48 3±2 0±51* 0±000 110 7±2 0±78 158 5±2 65±3 75±8
*P! 0±01, gender difference (χ#).
Table 2. Lifetime (LT ) prevalence of social fears in the total sample and among those with DSM-IV generalized (G-SP) and non-
generalized (NG-SP) social phobia with social fear conditional probabilities for diagnosis
LT-prevalence in total sample Prevalence among NG-SP Prevalence among G-SP Cond. prob. for diagnosis
Male Female Total Male Female Total Male Female Total Male Female Total
Social fear situation N % P N % N % N % N % N % N % P N % N % N % P N % N %
Eating or drinking
in public
36 2±4* 0±001 98 6±4 134 4±4 6 11±3 7 7±2 13 8±7 5 27±7 0±049 25 54±7 30 46±9 11 31±6 — 32 33±1 44 32±7
Writing while
someone watches
25 1±7* 0±04 42 2±8 67 2±2 0 0 4 3±8 4 2±4 4 22±5 — 10 21±1 14 21±5 4 17±0 — 14 32±1 18 26±5
Participating in
social events
44 3±0* 0±001 95 6±2 139 4±6 4 7±6 5 4±7 9 5±7 13 70±5 — 30 64±5 43 66±2 17 39±3 — 34 36±2 52 37±2
Performance}test
situations
215 14±4 0±001 334 21±9 550 18±2 34 61±6 60 59±9 94 60±5 12 66±0 0±051 40 87±0 52 81 46 21±5 0±029 100 29±9 146 26±6
Public speaking (in
front of others)
159 10±7 0±001 239 15±6 398 13±2 25 45±7 46 45±9 71 45±8 14 75±4 — 42 91±4 56 86±8 39 24±6 0±011 88 36±8 127 31±9
Talking with}to
others (social talk)
63 4±2* 0±001 131 8±5 194 6±4 9 15±9 12 12±1 21 13±5 15 78±8 — 35 75±5 49 76±5 23 37 — 47 35±9 70 36±2
Any social fear 334 22±3 0±001 492 32±2 826 27±3 — — — — — — — — — — — — — — — — — — — —
*P! 0±05, gender difference (χ#).
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F. 1. Cumulative hazard function of generalized (E, women; _, men) and non-generalized (D, women; ^, men) social phobia,
by gender.
Social fears and social phobics
Subjectively perceived unreasonably strong fears
of doing things in front of other people or being
in the centre of attention are much more
widespread in our sample than social phobia as
a diagnosis (Table 2). A persistent strong fear of
this type at some time in their life, was
acknowledged by 22±3% of male and 32±2% of
female respondents. Women were significantly
more likely to report these fears than men and
were slightly more likely to report multiple fears
than men (P! 0±04). The lifetime prevalence of
specific social fears ranged from a low of 2±1%
for unreasonably strong fear of writing while
someone watches, to a high of 18±2% for
unreasonably strong fears of tests and examin-
ations even though well prepared. Overall,
the second most prevalent fear was public
speaking (13±2%) in front of a group of people
in class or meetings.
Non-generalized social phobics are mainly
characterized by fear of test}performance
(60±5%) and of speaking in front of a group
(45±8%). Typical examples given by social
phobics in this age group mainly to school-
related speaking situations. The only other
noteworthy type of fear reported was talking to
or with others. Examples given indicate that
respondents with this type of fear referred mostly
to situations that could be summarized best
under the heading ‘dealing with authorities ’.
Respondents with generalized social phobia
differed markedly with regard to a higher
frequency of almost all social fears as well as a
more general nature of their verbatim examples.
In an attempt to identify whether any specific
social fear is associated particularly with social
phobia, conditional probabilities (CP) of a
DSM-IV diagnosis of social phobia given each
of the six social fear clusters were calculated. We
could not identify interpretable subtype-specific
patterns of symptomatology. The only two
noteworthy differences were: (a) higher overall
rates of symptoms; and (b) higher rates of fear
of humiliation among generalized social phobics.
CPs were found to range from a low of 26±5%
for fear of writing to a high of 37±2% for
participating in social events. CPs of social
phobia among those with a fear were found to
3
1
6
H
.-U
.
W
ittch
en
a
n
d
o
th
ers
Table 3. Lifetime association of social phobia with selected psychiatric disorders
Any Non-generalized Generalized
Row Dx % by Row Dx % by Row Dx % by
phobia status Univariate† phobia status Univariate† phobia status Univariate†
Co-occurring disorders No Yes POR 95% CI No Yes POR 95% CI No Yes POR 95% CI
Any of the disorders below 46±1 72±1 2±79* (1±96–3±98) 46±1 65±5 2±01* (1±35–2±99) 46±1 87±8 8±26* (3±56–19±18)
Substance disorders 27±9 41±3 1±64* (1±17–2±30) 27±9 37±6 1±39 (0±93–2±07) 27±9 50±0 2±45* (1±37–4±38)
Nicotine 17±8 31±9 2±00* (1±40–2±86) 17±8 28±7 1±70* (1±10–2±61) 17±8 39±5 2±89* (1±58–5±28)
Alcohol ab}dep 15±6 19±4 1±14 (0±76–1±72) 15±6 19±3 1±12 (0±69–1±81) 15±6 19±5 1±19 (0±58–2±46)
Illicit drugs ab}dep 4±3 7±5 1±67 (0±89–3±13) 4±3 6±9 1±52 (0±71–3±26) 4±3 8±9 2±06 (0±74–5±74)
Any depressive disorders 12±1 31±1 3±04* (2±11–4±37) 12±1 25±5 2±26* (1±45–3±54) 12±1 44±4 5±58* (3±07–10±14)
Major depression 10±4 25±5 2±69* (1±82–3±98) 10±4 22±5 2±25* (1±40–3±61) 10±4 32±5 3±95* (2±07–7±51)
Dysthymia 2±4 10±9 5±03* (2±83–8±95) 2±4 3±7 1±54 (0±59–4±04) 2±4 28±4 16±29* (8±06–32±95)
Any anxiety disorders 20±8 49±9 3±71* (2±68–5±13) 20±8 43±0 2±79* (1±90–4±10) 20±8 66±5 7±44** (4±16–13±30)
Panic disorder w}wo AG 1±3 6±2 4±68* (2±14–10±27) 1±3 4±5 3±31* (1±22–9±00) 1±3 10±1 8±32* (2±79–24±82)
Agoraphobia w}o PD 1±8 8±8 5±45* (2±87–10±34) 1±8 4±3 2±45 (0±92–6±52) 1±8 19±7 13±81* (6±30–30±27)
Specific phobias (­NOS) 17±3 43±6 3±67* (2±63–5±10) 17±3 38±9 3±02* (2±04–4±46) 17±3 55±0 5±80* (3±28–10±25)
GAD 0±8 2±3 2±42 (0±82–7±11) 0±8 0±3 0±32 (0±04–2±55) 0±8 6±9 8±10* (2±53–25±90)
OCD 0±6 2±3 3±95* (1±25–12±48) 0±6 1±3 2±03 (0±41–10±04) 0±6 4±8 8±26* (2±13–31±97)
PTSD 1±0 5±9 6±23* (2±72–14±26) 1±0 0±7 0±69 (0±09–5±23) 1±0 18±5 22±65* (9±26–55±40)
Eating disorders 2±6 5±7 1±99 (0±93–4±27) 2±6 1±8 0±60 (0±14–2±60) 2±6 15±0 6±18* (2±54–15±05)
Dx, diagnosis ; POR, prevalence odds ratio ; CI, confidence interval.
† Controls for age.
* χ#
"
, P! 0±05.
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Table 4. Current social role impairments, work productivity, help-seeking and treatment in 12-month pure and co-morbid generalized
(G-SP) and non-generalized (NG-SP) social phobia
12-month DSM-IV social phobics
NG-social phobia G-social phobia Total social phobia
Pure
(N¯ 55)
Co-morbid
(N¯ 47)
Total
(N¯ 102)
Pure
(N¯ 11)
Co-morbid
(N¯ 46)
Total
(N¯ 57)
Pure
(N¯ 66)
Co-morbid
(N¯ 93)
Total
(N¯ 159)
N % P N % N % N % P N % P N % N % P N % N %
Current social role
impairments
Work}school}household 16 28±4 — 16 33±9 32 31±4 7 63±6u 0±028 25 55±2u 0±04 32 56±7 22 34±1* 0±190 41 44±4 63 40±2
Leisure time activities 3 5±0 — 15 31±0 18 17±6 1 10±0 — 16 35±5 — 17 30±8 4 5±8* 0±001 31 33±2 35 21±9
Social contacts}partner
relationship
2 3±1 — 7 14±6 9 8±8 2 19±5u 0±037 18 39±1u 0±008 20 35±5 4 5±7* 0±001 25 26±7 29 18±1
Work days lost}productivity
Missed " 2 days}mo 0 0 — 0 0 0 0 0 0 — 9 18±7u 0±002 9 15±2 0 0 — 9 9±2 9 5±4
Diminished work
productivity " 2
9 15±8 — 16 34±3 25 24±3 0 0* 0±012 20 43±2 — 20 35±2 9 13±2* 0±001 36 38±7 45 28±2
Help-seeking because of social
phobia
Any medical doctor 3 5±6 — 2 4±3 5 5±0 1 10±0 — 14 30±4u 0±001 15 26±8 5 7±7 — 16 17±2 21 13±3
Any other MH-professional 2 3±6 — 5 10±6 7 6±9 1 10±0 — 6 13±0 — 7 12±5 3 4±6 — 11 11±8 14 8±9
Total any help-seeking 6 10±9 — 7 14±9 13 12±7 3 27±3 — 20 43±5u 0±002 23 40±4 8 12±3* 0±019 26 28±0 34 21±5
* P! 0±05 pure v. co-morbid (χ#).
u P! 0±05 generalized versus non-generalized social phobia (χ#).
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be significantly greater for females than males. It
is noteworthy that the CP of social phobia
increases steadily with number of social fears
reported, from a low of 22±4% for those with
just one social fear to a high of 62±2% for those
with five or six fears.
Age of first onset of social phobia
Kaplan-Meier cumulative age of onset curves
based on retrospective reports were computed
separately for males and females. As shown in
Fig. 1, the curves between non-generalized and
generalized types differ significantly (log rank:
4,93, df¯ 1, P¯ 0±0265). Most social phobias
among respondents in the age range of the
sample start between ages 10 and 21. But the
generalized type has a significantly lower median
age of onset (11±5 v. 14 for males, P! 0±004 and
12±5 v. 15 for females, P! 0±003) than non-
generalized social phobia.
Co-morbidity
Table 3 presents data on co-morbidities of
lifetime social phobia with other DSM-IV}CIDI
disorders. When controlling for gender and
birth cohort only a few significant (P! 0±05)
and relatively modest associations were found
between non-generalized social phobia and the
other disorders considered here. Co-morbidities
are much stronger and consistent for generalized
social phobia, especially with regard to specific
phobia (OR¯ 16±4), post-traumatic stress dis-
order (OR¯ 17±3), and dysthymia (OR¯ 13±7).
A more detailed analysis revealed that taking a
time difference of at least 1 year, social phobia
precedes 85±2% of the co-morbid substance use
disorders, 81±6% of the depressive disorders and
64±4% of the other anxiety disorders, with
specific phobia being the only co-morbid con-
dition for which earlier ages of onset were
reported relatively frequently.
The significant associations of social phobia
with eating disorder and panic disorder deserve
attention because of the possibility that in the
first case social phobia might occur only as part
of the characteristic symptom cluster of eating
disorders and in the second case that social
phobia might be part of panic-related avoidance
behaviour. A case-by-case review of all eating
disorders revealed that this assumption is rather
unlikely because of the following reasons: (a) all
but two of these cases have several social fears,
not just fears of eating and drinking with others ;
(b) the onset of social fears occurred in most
cases before the onset of the eating disorders ;
and (c) only few cases with any eating disorder
had a full-blown CIDI-DSM-IV diagnosis
‘anorexia nervosa’ or ‘bulimia’, but rather binge
eating or subthreshold eating disorder (NOS).
For panic disorder we found that although
social fears are very frequent, the separate
diagnosis of panic disorder is justified in all
cases, because of : (a) the consistently earlier age
of onset of social phobia than panic disorder ; (b)
the panic disorder cases’ report that panic
attacks only sometimes occur in social fear
situations; and (c) the primary cognitions of
panic disorder cases of being afraid of getting
another unexpected attack, having to die, or to
get a heart attack, that are not reported by social
phobics in the M-CIDI social phobia section.
Impairments, help-seeking and treatment
The upper part of Table 4 presents data on
current social phobia-specific role impairments
among those with diagnoses of pure and co-
morbid 12-month social phobia. Impairments in
work, school or household management, but
not with regard to leisure time activities, are
more frequent in pure (P¯ 0±028) and co-
morbid (P¯ 0±04) generalized than non-
generalized social phobics. The presence of co-
morbid conditions is associated consistently with
increased social-role impairments. About one-
fifth of co-morbid generalized social phobics
indicated having been unable to go to school or
work for more than 2 days in the past month
because of their social phobia. In addition, a
substantial proportion of co-morbid generalized
(43±2%) and non-generalized (34±3%) social
phobics reported significantly diminished work
productivity.
The lower part of Table 4 reports findings
about professional help-seeking and treatment.
Smaller proportions of those with pure (10±9%)
and co-morbid (14±9%) non-generalized social
phobia than those with pure generalized (27±3%)
or co-morbid generalized (43±5%) social phobia
contacted a MD or another mental health
specialist (in the vast majority subjects indicated
a psychologist) specifically because of their social
phobia at some time in their life. It should be
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Table 5. Lifetime association of social phobia with sociodemographic and developmental factors
Any social phobia Non-generalized Generalized
POR 95% CI POR 95% CI POR 95% CI
Type of education†
Hauptschule 1±26 (0±75–2±10) 1±09 (0±59–2±02) 1±72 (0±71–4±16)
Fachhochschule 1±35 (0±69–2±65) 1±35 (0±63–2±92) 1±37 (0±38–4±94)
Realschule 1±40 (0±92–2±13) 1±33 (0±81–2±16) 1±59 (0±74–3±41)
Gymnasium 1±00 1±00 1±00
University 1±18 (0±80–1±74) 1±13 (0±72–1±77) 1±33 (0±65–2±72)
Living arrangement
With parents 1±00 1±00 1±00
Alone 1±40 (0±99–1±96) 1±29 (0±84–1±96) 1±59 (0±92–2±77)
With partner 1±38 (0±88–2±17) 1±94* (1±19–3±17) 0±31 (0±08–1±20)
With spouse 1±02 (0±51–2±05) 1±58 (0±77–3±25) —
Subjective financial situation†
Bad 1±67* (1±06–2±64) 1±48 (0±85–2±57) 2±12 0±99–4±54)
OK 1±36 (0±99–1±86) 1±25 (0±86–1±82) 1±65 (0±95–2±85)
Good 1±00 1±00 1±00
Very good 0±93 (0±56–1±55) 1±16 (0±68–2±00) 0±35 (0±08–1±44)
Urbanicity†
Suburbs 1±00 1±00 1±00
Urban Munich 1±06 (0±76–1±47) 0±98 (0±67–1±43) 1±30 (0±69–2±42)
Developmental risk factors
Behavioural inhibition (z" 0±49) 4±54* (3±38–6±09) 2±92* (2±10–4±06) 23±73* (10±12–56±68)
Separated from parent 2±13* (1±57–2±89) 1±79* (1±24–2±59) 3±06* (1±83–5±11)
Parental separation 1±82* (1±36–2±43) 1±60* (1±13–2±26) 2±42* (1±47–4±00)
Parental history
Mental problems 2±01* (1±51–2±68) 1±80* (1±29–2±50) 2±68* (1±57–4±58)
Treatment 1±84* (1±28–2±64) 1±99* (1±32–3±00) 1±52 (0±78–2±97)
Problems 2±19* (1±65–3±91) 1±92* (1±38–2±66) 3±08* (1±81–5±26)
Substance problems 1±65* (1±21–2±24) 1±29 (0±88–1±88) 2±73* (1±65–4±54)
Treatment 1±83* (1±17–2±85) 1±45 (0±83–2±56) 2±81* (1±43–5±50)
Problems 1±73* (1±27–2±35) 1±35 (0±93–1±97) 2±87* (1±73–4±76)
Dx, diagnosis ; POR, prevalence odds ratio ; CI, confidence interval.
† Controls for gender and birth-cohort.
* χ#
"
, P! 0±05.
noted that these findings do not necessarily
mean that adequate treatment was actually
provided.
Risk factors and correlates of non-generalized
and generalized social phobia
When controlling for age and gender, only a few
psychosocial correlates of social phobia were
identified in Table 5. Although we examined
several other variables ranging from social class
to social network variables, only poor financial
situation (OR¯ 1±67) and, surprisingly, living
with a partner (1±94) revealed significant
associations with non-generalized social phobia.
Developmental variables were more strongly
related to generalized social phobia, including
retrospectively assessed high ‘behavioural in-
hibition’ between ages 5 to 12, ‘ long-lasting
separation from either parent during childhood
or early adolescence’ and ‘parental history of
psychopathology’. The bivariate associations
suggest, that all of these variables, particularly
behavioural inhibition, are much more strongly
related to the onset of generalized social phobia
than non-generalized social phobia.
DISCUSSION
This community study reporting data on the
prevalence, clinical characteristics, impairments,
risk factors and co-morbidity patterns of DSM-
IV social phobia in 3021 respondents aged 14–24
confirms that social phobia is a quite prevalent
disorder in this age group. In comparison with
previous epidemiological studies with consider-
ably broader age groups (Schneier et al. 1992;
Davidson et al. 1993; Degonda & Angst, 1993;
Magee et al. 1996), the focus on a sample of
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adolescents and young adults allows a more
detailed description of early stages of this
disorder, before more severe complications are
present (Hazen & Stein, 1995). We find that
DSM-IV social phobia, with a lifetime rate of
9±5% for females and 4±9% for males, is
considerably more prevalent than in the early
DSM-III}DIS studies but not as prevalent as in
the more recent DSM-III-R}CIDI studies
(ranging from 13±3 to 16%) that have been
based on samples with an age range, extending
throughout adulthood. Our higher prevalence
than in the DIS studies is probably due to a
more complete assessment of qualifying social
fears and especially the younger age groups in
the current study, whereas the lower rates as
compared to the NCS (Magee et al. 1996), which
used DSM-III-R, might be due to the use of
stricter impairment and distress criteria as well
as a more refined symptom assessment in DSM-
IV. Although these prevalence were estimated
without taking into account the diagnostic
exclusion criteria for DSM-IV, a closer in-
spection revealed that in this young age group,
none of the DSM-IV axis I diagnostic
exclusionary considerations examined (sub-
stances, somatic conditions, mental disorders)
plays a critical role. As a limitation, however,
one should acknowledge that our study does not
allow to investigate the relationship to avoidant
and other personality disorders.
Although there is still considerable contro-
versy about whether generalized social phobia is
a distinct clinical syndrome and even more
disagreement about its diagnostic assessment
(Heimberg et al. 1990, 1993; Manuzza et al.
1995), our findings provide epidemiological
support for the usefulness of the DSM-IV
subtype of generalized social phobia.
‘Generalized social phobia’ as defined in this
paper simply by number of trigger situations,
differs markedly from non-generalized social
phobia not only in symptomatology, age of
onset patterns, co-morbidity, impairment, and
treatment rates, but also with regard to the
degree of associations with several family and
developmental variables, such as retrospectively
assessed parental psychopathology, early sep-
aration from either parent and childhood in-
hibition. Non-generalized social phobics in this
age group are described best as respondents
experiencing fear reactions and avoidance in test
and performance situations in school or other
educational settings or less frequently in dealing
with authorities. The generalized subtype is not
only characterized by: (a) social fears in many or
even all types of situational clusters assessed:
and (b) by a higher number of associated
symptoms, such as fear of humiliation, panic-
like symptoms and extreme distress : but (c) as
judged from the verbatim examples – also
reveals a more generalized fear and avoidance
pattern in everyday interactional situations.
Most frequent examples were persistent every-
day social fear situations like ‘ talking to others,
asking for directions, initiating contacts, partici-
pating in any type of social event and being
fearful in any situation where he or she might be
in the center of attention of others ’. These more
general interactional fears, characteristic of
generalized social phobia, were found to start
considerably earlier in life than test and per-
formance as well as public speaking fears
characteristic for non-generalized social phobia.
The cumulative age of onset curve suggests that
50% of the generalized, but only 19% of the
non-generalized, social phobics started before
the age of 12. In light of the early onset of
generalized social phobia, it should be noted as
a limitation that this study made no attempt to
assess the role of particular types of personality
disorders and did not explore the role of other
potentially important subtypes of social phobia
considered by the APA-DSM-IV Task Force
(Heimberg et al. 1993). It also should be noted
that the definition of generalized phobia is
limited by the number and the specific types of
situations included in the M-CIDI.
Consistent with many other studies (Schneier
et al. 1992; Magee et al. 1996), social phobia was
found to be highly co-morbid with other mental
disorders, particularly other anxiety disorders
and depressive disorders. But it is important to
note that the diagnostic overlap is mainly driven
by the generalized subtype. For non-generalized
social phobias only very few significant, rather
moderate odds ratios were found. In contrast,
more than two-thirds of generalized social
phobics reported a history of at least one other
M-CIDI disorder, with highest odds-ratios for
anxiety disorders and dysthymia (13±7), mod-
erate odds-ratios for eating disorder (4±9), major
depressive episodes (3±5) and nicotine depen-
dence (2±9), but not other types of substances use
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disorders. Given that co-morbidity rates
increased steadily by age group, and that the
vast majority of these co-morbid conditions,
except for simple phobia, had a considerably
later age of onset than social phobia, we can
assume that generalized social phobia among
adolescents and young adults is a risk factor for
the subsequent development of other mental
disorders. Contrary to the findings in studies in
adults, however, we could not yet find high co-
morbidity with alcohol use disorders (Schneier
et al. 1992; Magee et al. 1996) or with secondary
major depressive episodes (Van Ameringen et al.
1991).
The impairment findings are especially strik-
ing in that they suggest that generalized social
phobia can be quite impairing even in fairly
young age groups, especially with regard to
school and work performance. This result is
consistent with other recent research on the
impact of chronic social phobia in adults
(Davidson et al. 1993, 1994; Wittchen & Beloch,
1996; Kessler et al. 1999) and shows that this
condition is, in fact, a very important one from
a health economic and public health perspective.
It is also essential to note that this is true also for
pure generalized social phobia, although the
presence of co-morbid conditions increases
substantially the degree and the frequency of
impairments and disability related to social
phobia. Non-generalized social phobia – at least
in 14- to 24-year-olds – however, is less persistent
and less frequently associated with considerable
impairments, unless complicated by co-mor-
bidity.
We also confirm previous findings (Magee et
al. 1996) of overall low treatment utilization,
with approximately only one out of four lifetime
social phobics ever having received some kind of
mental health treatment for this condition. This
finding was unexpected in light of the fact that
the German health care system offers almost
everybody free access to a wide range of mental
health care free of charge. Nevertheless, our
rates for social phobia-specific help-seeking and
treatment rates are only slightly higher than
estimates from the US. Magee et al. 1996)
reported for the NCS professional help-seeking
rates with identical questions of 19% as com-
pared to 22% in the present study.
Concerning risk factors for onset, it is note-
worthy that aside from the effect from gender,
poor financial situation and living with a partner,
we could not replicate earlier positive
associations of poor educational status, never
been married, being unemployed or homemaker
and living with parents with social phobia
(Magee et al. 1996). This failure might be
explained with the fairly young age group used
in our study and suggests that these variables are
rather consequences of the long-term course
than risk factors for the onset of social phobia.
In agreement with some genetic and family
genetic studies suggesting a moderate heritability
of social phobia and a moderate threefold
increased relative risk (Knowles et al. 1995;
Stein et al. 1998), we find that respondents
reporting a positive family history of mental
problems, particularly anxiety and depressive
disorders, are significantly more likely to have
generalized social phobia. Also, other retro-
spectively reported developmental predictors
were significant, such as early separation from
either parent and, most impressively,
behavioural inhibition. Our findings concerning
the childhood temperament construct of
behavioural inhibition to the unfamiliar is in
agreement with hypotheses (Kagan, 1989) as
well as the work of Biederman et al. (1990)
suggesting that behavioural inhibition might be
an important construct for describing early
individual vulnerabilities and risks for the onset
of generalized and possibly non-generalized
social phobia.
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